Our client, a leading Chinese securities firm in Hong Kong, is seeking an Equity Research Analyst to cover the Healthcare sector, with a focus on Hong Kong-listed pharmaceutical companies. The ideal candidate will possess a hybrid background combining expertise in life sciences/medicine with strong financial analysis skills.
Key Responsibilities :
- Independently conduct in-depth research and analysis on Hong Kong-listed pharmaceutical enterprises, covering sub-sectors such as biotech, innovative pharmaceuticals, and healthcare services.
- Develop and maintain detailed financial models to evaluate company valuations, growth drivers, and risk exposures (e.g., regulatory approvals, patent cliffs).
- Produce high-quality, actionable research reports including thematic studies, company-specific updates, and sector reviews covering regulatory shifts, clinical trials, and product launches.
- Monitor and interpret global pharmaceutical industry trends (e.g., novel therapies, M&A, FDA/EMA regulations) and assess their impact on Hong Kong-listed equities.
- Engage with internal teams (especially mainland China-based pharmaceutical analysts) to align research views, share insights on cross-border trends, and ensure cohesive cross-market analysis.
- Communicate investment recommendations effectively through written reports, client meetings, and formal presentations tailored to both financial and non-financial audiences.
- Attend industry conferences, conduct company site visits, and network with key opinion leaders (e.g., clinicians, consultants) to enhance sector expertise.
Requirements
- Masters or higher in Life Sciences (Biochemistry, Microbiology, etc.), Medicine, Pharmacy, Finance, or Economics. Advanced degrees (PhD, MBA) or professional certifications (CFA, FRM) are strongly preferred.
- Minimum 2 years of sell-side equity research experience focusing on the healthcare/pharmaceutical sector; familiarity with Hong Kong markets and HKEX regulations is a significant advantage.
- Demonstrated ability to independently manage sector coverage, generate investment ideas, and support decision-making through rigorous analysis.
- Proficiency in translating complex scientific/medical data (e.g., clinical trial results) into investable insights.
- Strong financial modeling skills and familiarity with data analysis tools.
- Fluency in English and Mandarin (written and spoken); exceptional communication and presentation skills.
Ideal Profile
The successful candidate will be a proactive, detail-oriented analyst with a passion for the healthcare sector and the ability to work both independently and collaboratively within a cross-border team. Prior exposure to Hong Kong or Greater China equity markets is highly valued.